Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-(-)-oxiracetam for injection in traumatic brain injury cognitive impairment
CTR20170517Phase 2Completed
- Sponsor
- Nanjing Yoko Pharmaceutical
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Oxiracetam in traumatic brain injury (TBI), confusion, sponsored by Nanjing Yoko Pharmaceutical. Started Aug 2017; status: completed.
02
Drugs
Oxiracetam
03
Conditions
traumatic brain injury (TBI)confusion
Beyond the preview
Go deeper on CTR20170517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170517.